Episode
Neuromyelitis Optica Spectrum Disorder With Dr. Sara Mariotto
- Podcast
- Continuum Audio
- Published
- Apr 29, 2026
- Duration seconds
- 1620
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/continuum-audio-6777185/episodes/neuromyelitis-optica-spectrum-disorder-with-dr-sara-mariotto/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/continuum-audio-6777185/neuromyelitis-optica-spectrum-disorder-with-dr-sara-mariotto.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Although rare, recognizing NMOSD is crucial for improving patient outcomes through correct diagnostic and treatment approaches. Reports of atypical forms and increasing knowledge of clinical, imaging, and laboratory-specific features are fundamental for the accurate recognition of this condition. Research on targeted therapies and biomarkers measuring and predicting disease activity will improve NMOSD management. In this episode, Gordon Smith, MD, FAAN, speaks with Sara Mariotto, MD, PhD, coauthor of the article "Neuromyelitis Optica Spectrum Disorder" in the Continuum ® April 2026 Multiple Sclerosis and Related Disorders issue. Dr. Smith is a Continuum® Audio interviewer and a professor and chair of neurology at Kenneth and Dianne Wright Distinguished Chair in Clinical and Translational Research at Virginia Commonwealth University in Richmond, Virginia. Dr. Mariotto is a neurologist in the Neurology Unit in the Department of Neurosciences, Biomedicine, and Movement Sciences at the University of Verona in Verona, Italy. Additional Resources Read the article: Neuromyelitis Optica Spectrum Disorder Subscribe to Continuum® : shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @GordonSmithMD Full episode transcript available here Dr Smith: Neurology is an increasingly therapeutic specialty, and across many of our subspecialty areas, lots of new drugs are being approved. Are you interested in learning more about a historically disabling disorder for which we now have a spectrum of new therapies that,…